August 18, 2021
RENGEN-COV
This week the FDA approved RENGEN-COV under an emergency use authorization. The treatment works by attaching monoclonal antibodies to the novel coronavirus when it first enters the body and preventing it from invading new cells and replicating. This treatment is for adults and children over age 12 exposed to SARS-CoV-2 who might be at high risk of developing severe COVID-19....
